IL33 and Alzheimer disease: In contrast, while AD mice exhibited a significant decrease in IL-33 and increases in CCL-2 and CCL-5 relative to WTs, there was no significant effect of these mediators following IL-21 or IL-21R injection in AD mice (Fig. 5H–J).